EAM Investors’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-126,704
Closed -$741K 347
2023
Q4
$741K Sell
126,704
-243,275
-66% -$1.28M 0.13% 186
2023
Q3
$1.91M Hold
369,979
0.37% 109
2023
Q2
$1.78M Buy
+369,979
New +$1.28M 0.33% 128

Other funds holding AUGX

EAM Investors's AUGX Position: Q1 2024 in Review

EAM Investors sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2024, closing a stake of 126,704 shares — an estimated $741K sold.

EAM Investors first reported a position in AUGX in Q2 2023 and held it in 3 quarters. The position peaked at $1.91M in Q3 2023. 84 funds tracked by Wall St. Rank hold AUGX as of Q1 2024.

  • EAM Investors reported no remaining Augmedix, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • EAM Investors sold 126,704 Augmedix, Inc. Common Stock shares in Q1 2024, an estimated $741K.
  • EAM Investors first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • EAM Investors's Augmedix, Inc. Common Stock position peaked at $1.91M in Q3 2023.
  • 84 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2024.

Based on EAM Investors's 13F filing for Q1 2024, filed 13 May 2024.